News

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET

ASHBURN, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release its fourth quarter and 2023 financial results after the market closes on Wednesday, March 13, 2024.

03/07/2024

Why Is Quoin Pharmaceuticals (QNRX) Stock Down 50% Today?

Quoin Pharmaceuticals (NASDAQ: QNRX ) stock is falling on Tuesday after the clinical-stage specialty pharmaceutical company announced details of a public offering for its shares. The public offering has Quoin Pharmaceuticals selling 4,062,500 shares of QNRX stock for $1.60 each.

03/05/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Quoin Pharmaceuticals, Ltd. (QNRX) a buy, sell, or hold?

Quoin Pharmaceuticals, Ltd. (QNRX) can hold. Click on Rating Page for detail.

What is Quoin Pharmaceuticals, Ltd.'s stock price?

The price of Quoin Pharmaceuticals, Ltd. (QNRX) is 0.6375 and it was updated on 2024-04-27 07:00:44.

Is Quoin Pharmaceuticals, Ltd. (QNRX) overvalued or undervalued?

Currently Quoin Pharmaceuticals, Ltd. (QNRX) is in undervalued.

News

From:

To:

News
Quoin Pharmaceuticals, Ltd. (QNRX) Q3 2023 Earnings Call Transcript Quoin Pharmaceuticals, Ltd. (QNRX) Q3 2023 Earnings Call Transcript Thu, Nov. 09, 2023
Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release its third quarter 2023 financial results after the market closes on Wednesday, November 8, 2023. Fri, Nov. 03, 2023
Quoin Pharmaceuticals, Ltd. (QNRX) Q2 2023 Earnings Call Transcript Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX ) Q2 2023 Results Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Gordon Dunn - Chief Financial Officer Michael Myers - Co-Founder, Chairman and Chief Executive Officer Conference Call Participants Naz Rahman - Maxim Group Laura Suriel - Alliance Global Partners Operator Good morning. Mon, Aug. 07, 2023
Why Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today? Quoin Pharmaceuticals (NASDAQ: QNRX ) stock is taking a massive beating on Monday as the company prepares for an ADS ratio change. According to a filing from Quoin Pharmaceuticals, the company is enacting an ADS ratio change that will switch its stock from one for 5,000 shares to one for 6,000 shares. Mon, Jul. 17, 2023
Quoin Pharmaceuticals Announces 2022 Corporate Update Conference Call to be held on Thursday March 9th at 8:30am ET ASHBURN, Va., March 02, 2023 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company intends to release its 2022 fourth quarter and year-end financial results after the market closes on Wednesday, March 8, 2023. Thu, Mar. 02, 2023

Transcripts

Transcipts Data
Quoin Pharmaceuticals, Ltd. (QNRX) on Q3 2023 Results - Earnings Call Transcript SA Transcripts Thu, Nov. 09, 2023
Quoin Pharmaceuticals, Ltd. (QNRX) on Q2 2023 Results - Earnings Call Transcript SA Transcripts Mon, Aug. 07, 2023
Quoin Pharmaceuticals, Ltd. (QNRX) on Q1 2023 Results - Earnings Call Transcript SA Transcripts Fri, May. 12, 2023
Quoin Pharmaceuticals, Ltd. (QNRX) on Q4 2022 Results - Earnings Call Transcript SA Transcripts Thu, Mar. 09, 2023
Quoin Pharmaceuticals, Ltd. (QNRX) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Thu, Nov. 10, 2022
Quoin Pharmaceuticals, Ltd. (QNRX) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Thu, Aug. 18, 2022

SEC Filings

SEC Filings
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 04/09/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 04/04/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - DEFA14A SEC Filings 04/02/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - POS AM SEC Filings 03/29/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 10-K - Current report SEC Filings 03/14/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 03/13/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 03/08/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 03/08/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 03/06/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B4 SEC Filings 03/06/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 03/04/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - DEF 14A SEC Filings 02/27/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 02/15/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 02/13/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - S-1/A SEC Filings 02/13/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - PRE 14A SEC Filings 02/13/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - S-1 SEC Filings 02/12/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 01/31/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 01/30/2024
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 12/18/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 12/18/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 11/09/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 11/09/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 10-Q - Quarterly Report SEC Filings 11/09/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 11/07/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 11/06/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 11/01/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 11/01/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 4 SEC Filings 10/30/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - DEFA14A SEC Filings 10/19/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 09/14/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 09/13/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - DEF 14A SEC Filings 09/12/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - ARS SEC Filings 09/12/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - PRE 14A SEC Filings 09/01/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 08/03/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 10-Q - Quarterly Report SEC Filings 08/03/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 08/02/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 07/18/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K/A - Current report SEC Filings 07/14/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 06/28/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 06/28/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 05/12/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 05/12/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 05/09/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 10-Q - Quarterly Report SEC Filings 05/09/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 05/08/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 04/07/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 04/07/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 03/22/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 03/20/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - S-8 SEC Filings 03/15/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - POS AM SEC Filings 03/15/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 10-K - Current report SEC Filings 03/15/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 03/09/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 3/A SEC Filings 03/07/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 3 SEC Filings 03/07/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 03/03/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-K - Current report SEC Filings 02/28/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 02/28/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B4 SEC Filings 02/23/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 02/14/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 02/13/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - S-1/A SEC Filings 02/09/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - S-1 SEC Filings 02/03/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 3 SEC Filings 01/03/2023
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/10/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 11/10/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/07/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 11/07/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/28/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 10/28/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/21/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 09/21/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - D SEC Filings 08/31/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/18/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 08/18/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 08/12/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - POS EX SEC Filings 08/11/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/11/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 08/11/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B4 SEC Filings 08/09/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 08/08/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 08/08/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B4 SEC Filings 08/08/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1MEF SEC Filings 08/05/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 08/04/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 08/04/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 08/03/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1 SEC Filings 08/03/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1 SEC Filings 08/02/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 07/15/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 07/15/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - RW SEC Filings 06/30/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/17/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 06/17/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/16/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 06/16/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-3 SEC Filings 06/14/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/13/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 06/13/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/06/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 06/06/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/23/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 05/23/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/28/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 04/28/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 04/26/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 04/25/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 04/25/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 04/22/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 04/21/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1 SEC Filings 04/15/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1 SEC Filings 04/14/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F SEC Filings 04/14/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/13/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F SEC Filings 04/13/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/28/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 03/10/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/08/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 02/14/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 02/10/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/08/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/07/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/31/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/12/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/11/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 12/20/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 12/17/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/23/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 11/12/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/29/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/15/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/27/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/20/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/17/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/10/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/02/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/24/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 08/13/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/13/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 08/12/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - F-4/A SEC Filings 08/10/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 08/10/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - F-4/A SEC Filings 08/06/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 08/05/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 25-NSE SEC Filings 08/03/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 07/30/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - F-4/A SEC Filings 07/16/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 07/16/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 06/30/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/17/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - F-4 SEC Filings 06/16/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/03/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/19/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/29/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F SEC Filings 03/29/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/24/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 02/16/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K/A - Current report SEC Filings 02/11/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 01/13/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/20/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/09/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/02/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/29/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/22/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/20/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/13/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/25/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/21/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/12/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/06/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F/A SEC Filings 08/04/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/03/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/27/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/21/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/18/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/12/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 05/12/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/11/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/27/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13D/A SEC Filings 04/22/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/22/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/03/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F SEC Filings 04/03/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/02/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/04/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 02/14/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/27/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 01/17/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 01/10/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/10/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B5 SEC Filings 01/10/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/08/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/07/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/06/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 01/03/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 12/30/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 12/23/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/25/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/19/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/07/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/06/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/07/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/22/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/13/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/12/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/06/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 07/30/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 07/08/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/25/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - S-8 SEC Filings 06/20/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/06/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/21/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/16/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/30/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 04/08/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/27/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - POS AM SEC Filings 03/26/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/22/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/18/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F SEC Filings 03/18/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/11/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13D/A SEC Filings 02/20/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 02/19/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 02/14/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/13/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 02/12/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B4 SEC Filings 02/11/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 02/08/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/08/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 02/07/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 02/06/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/05/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 02/04/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/28/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 01/24/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/24/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/23/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 01/03/2019
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1 SEC Filings 12/28/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 12/17/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/13/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/05/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/25/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/22/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/18/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/15/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/20/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/05/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/30/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 08/22/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/20/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/13/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - POS AM SEC Filings 08/09/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/09/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/07/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 07/25/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 07/09/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 07/06/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 07/05/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/28/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/24/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - S-8 SEC Filings 05/17/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/17/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/10/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 04/09/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/09/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - POS AM SEC Filings 03/21/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/19/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F SEC Filings 03/19/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 02/20/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 02/09/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - D SEC Filings 02/09/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 02/09/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 02/07/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 02/06/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 02/01/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/31/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B5 SEC Filings 01/31/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/29/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/16/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/04/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 01/03/2018
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1 SEC Filings 12/28/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 12/14/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K/A - Current report SEC Filings 11/28/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/22/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/07/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/02/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/25/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/19/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - D SEC Filings 09/19/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/08/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B5 SEC Filings 09/07/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/05/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/21/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 08/18/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - S-8 SEC Filings 08/17/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13D SEC Filings 08/16/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 08/16/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 08/10/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 08/10/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - POS AM SEC Filings 08/01/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - F-3 SEC Filings 08/01/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/01/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/26/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/14/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/12/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/09/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/05/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/01/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/30/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/17/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/10/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 05/09/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/04/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/03/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 04/07/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/04/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/03/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - POS AM SEC Filings 03/30/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/27/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/23/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F SEC Filings 03/23/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/22/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/16/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/13/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 03/03/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/02/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/21/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/17/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 02/14/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/14/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/08/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/06/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/30/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/18/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/12/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/09/2017
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/30/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - S-8 SEC Filings 11/28/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/28/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/10/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/27/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/26/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/19/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/13/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/06/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/01/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/31/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/25/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/17/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/11/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - RW SEC Filings 08/03/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B4 SEC Filings 08/01/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 07/29/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - CERTNAS SEC Filings 07/29/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 07/29/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 07/28/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 07/27/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - F-6 SEC Filings 07/27/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 07/27/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 07/27/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - 8-A12B SEC Filings 07/27/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 07/26/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 07/26/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - FWP SEC Filings 07/25/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 07/25/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 07/22/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 07/22/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 07/13/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1 SEC Filings 07/07/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - DRSLTR SEC Filings 07/01/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - DRS/A SEC Filings 07/01/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 06/17/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - DRS/A SEC Filings 05/26/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - DRSLTR SEC Filings 05/25/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 05/06/2016
Quoin Pharmaceuticals, Ltd. (QNRX) - DRS SEC Filings 04/08/2016

Press Releases

StockPrice Release
Quoin pharmaceuticals provides corporate update and announces fourth quarter and 2023 financial results 03/13/2024
Quoin pharmaceuticals announces fourth quarter and 2023 financial results and corporate update conference call to be held on thursday march 14th at 8:30 am et 03/07/2024
Skinvisible announces significant progress in licensee's clinical trials for invisicare formulation targeting nethertons syndrome 02/14/2024
Prism marketview biotech in motion spotlight: quoin receives fda clearance for netherton syndrome clinical optimization plan 12/13/2023
Quoin pharmaceuticals announces fda clearance of clinical optimization plan for qrx003 for netherton syndrome 12/13/2023
Quoin pharmaceuticals provides corporate update and announces third quarter 2023 financial results 11/08/2023
Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et 11/03/2023
Repeat -- quoin pharmaceuticals announces additional positive clinical data from open-label, single-arm clinical trial in netherton syndrome 10/24/2023
Quoin pharmaceuticals announces additional positive clinical data from open-label, single-arm clinical trial in netherton syndrome 10/24/2023
Quoin pharmaceuticals provides corporate update and announces second quarter 2023 financial results 08/02/2023
Quoin pharmaceuticals announces 50% enrollment in open label netherton syndrome clinical trial 05/24/2023
Quoin pharmaceuticals provides corporate update and announces first quarter 2023 financial results 05/08/2023
Quoin pharmaceuticals doses first patient in open label netherton syndrome clinical trial 03/21/2023
Quoin pharmaceuticals provides corporate update and announces fourth quarter and full year 2022 financial results 03/08/2023
Quoin pharmaceuticals announces 2022 corporate update conference call to be held on thursday march 9th at 8:30am et 03/02/2023
Quoin pharmaceuticals announces pricing of $7.0 million public offering 02/22/2023
Quoin pharmaceuticals announces dosing of first patient in clinical trial in netherton syndrome 12/13/2022
Quoin pharmaceuticals provides corporate update and announces third quarter 2022 financial results 11/10/2022
Quoin pharmaceuticals to report third quarter 2022 financial results and provide corporate update on november 10th 11/01/2022
Quoin pharmaceuticals announces plans to initiate a second clinical trial in netherton syndrome patients 10/18/2022
Quoin pharmaceuticals establishes patient specific website for ongoing netherton syndrome clinical study 09/13/2022
Quoin pharmaceuticals provides corporate update and announces second quarter 2022 financial results 08/18/2022
Quoin pharmaceuticals to report second quarter 2022 financial results and provide corporate update on august 18th 08/11/2022
Quoin pharmaceuticals announces pricing of $16.8 million upsized public offering 08/05/2022
Quoin pharmaceuticals and endo ventures limited enter into exclusive distribution and supply agreements 07/15/2022
Endo announces agreement for paladin labs to develop, commercialize and supply quoin pharmaceuticals' qrx003 in canada 07/15/2022
Quoin pharmaceuticals announces opening of first clinical site for netherton syndrome clinical study 07/06/2022
Quoin pharmaceuticals receives nasdaq deficiency notice regarding minimum bid price requirement 06/15/2022
Quoin pharmaceuticals announces licensing and distribution agreement with leading rare disease company for greater china 06/15/2022
Quoin pharmaceuticals: strategically building for future success 06/14/2022
Quoin pharmaceuticals announces fda clearance of ind for its lead asset, qrx003, for netherton syndrome 04/25/2022
Quoin pharmaceuticals targeting regulatory approvals for lead candidate for netherton syndrome in 2024 03/24/2022
Quoin pharmaceuticals announces submission of ind for its lead asset, qrx003, for netherton syndrome 03/15/2022
Quoin pharmaceuticals submits scientific advice briefing document to ema for its lead asset, qrx003, for netherton syndrome 03/10/2022
Quoin pharmaceuticals extends exclusive distribution agreement with er-kim for its lead asset, qrx003, for netherton syndrome 03/01/2022
Quoin pharmaceuticals signs exclusive distribution agreement with neopharm for its lead asset, qrx003, for netherton syndrome 02/17/2022
Changing lives, delivering value: quoin pharmaceuticals is making the balancing act look easy 02/08/2022
The r&d sweet spot: quoin pharmaceuticals delivering value-based drug development through rare and orphan disease therapeutics 12/14/2021
Quoin pharmaceuticals poised for rapid commercialization of promising pipeline 11/16/2021
Quoin pharmaceuticals and genpharm services sign exclusive license and distribution agreement for quoin's lead asset, qrx003 11/11/2021
Quoin pharmaceuticals signs exclusive licensing and distribution agreement with aft pharmaceuticals for its lead asset, qrx003 11/08/2021
Quoin pharmaceuticals appoints gordon dunn as chief financial officer 11/04/2021

More Headlines

News
Quoin Pharmaceuticals, Ltd. (QNRX) Q3 2022 Earnings Call Transcript Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX ) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Gordon Dunn - CFO Michael Myers - CEO Conference Call Participants Aydin Huseynov - Ladenburg Thalmann James Molloy - Alliance Global Partners Naz Rahman - Maxim Group Operator Good morning and welcome to the Quoin Pharmaceuticals Limited Third Quarter Financial Results and Business Update Call. 11/10/2022
Quoin Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10th ASHBURN, Va., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its third quarter 2022 financial results will be reported on Thursday, November 10, 2022 before the open of the financial markets. Management will also host a webcast and conference call on November 10, 2022 at 8:30 a.m. ET to discuss the results and provide a corporate update. 11/01/2022
10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022 Penny stocks to buy according to analysts in 2022. The post 10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 10/19/2022
7 Penny Stocks To Buy According To Top Wall Street Analysts Penny stocks to buy according to analysts in 2022. The post 7 Penny Stocks To Buy According To Top Wall Street Analysts appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 10/18/2022
Hot Penny Stocks To Watch Today As Stock Market Crash Continues Hot penny stocks to watch today. The post Hot Penny Stocks To Watch Today As Stock Market Crash Continues appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 09/20/2022
4 Penny Stocks Making A Comeback In September, Time To Buy? Penny stocks making a comeback to watch this week. The post 4 Penny Stocks Making A Comeback In September, Time To Buy? 09/07/2022
Quoin Pharmaceuticals, Ltd. (QNRX) CEO Michael Myers on Q2 2022 Results - Earnings Call Transcript Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX ) Q2 2022 Earnings Conference Call August 18, 2022 8:30 AM ET Company Participants Gordon Dunn - Chief Financial Officer Michael Myers - Chief Executive Officer Denise Carter - Chief Operating Officer and Director Conference Call Participants Naz Rahman - Maxim Group James Molloy - Alliance Global Partners Operator Good morning and welcome to the Quoin Pharmaceuticals Limited Second Quarter Financial Results and Business Update Call. 08/18/2022
Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th ASHBURN, Va., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its second quarter 2022 financial results will be reported on Thursday, August 18, 2022 before the open of the financial markets. Management will also host a webcast and conference call on August 18, 2022 at 8:30 a.m. ET to discuss the results and provide a corporate update. 08/11/2022
Why Is Quoin Pharmaceuticals (QNRX) Stock Up 93% Today? QNRX stock is nearly doubling after the company sought permission to cancel an announcement of share sales. The post Why Is Quoin Pharmaceuticals (QNRX) Stock Up 93% Today? 07/01/2022
Best Penny Stocks To Buy Right Now? 4 To Watch Under $1 Penny stocks under $1 to watch. The post Best Penny Stocks To Buy Right Now? 07/01/2022
Penny Stocks To Buy Now? 4 To Watch With Big News Penny stocks to watch The post Penny Stocks To Buy Now? 4 To Watch With Big News appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 06/06/2022
Why Quoin Pharmaceuticals Stock Is Trading Higher Quoin Pharmaceuticals (NASDAQ: QNRX) shares are trading higher Monday after the company announced it received U.S. Food and Drug Administration clearance to initiate clinical testing for its Investigational New Drug application for QRX003. QRX003 is Quoin's investigational product for. 04/25/2022
Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today What are the best penny stocks to buy today? The post Best Reddit Penny Stocks To Buy Now? 01/07/2022
Best Penny Stocks to Buy as 2021 Ends? 3 to Watch Right Now Making a penny stocks watchlist today? Check these three out The post Best Penny Stocks to Buy as 2021 Ends? 12/21/2021

Unlock

QNRX Ratings Summary

QNRX Quant Ranking